FOXO TechnologiesFOXO
About: FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. The company's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life. The Company manages and classifies its business into two reportable business segments: Healthcare; and Labs and Life.
Employees: 168
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
1.82% less ownership
Funds ownership: 3.28% [Q4 2024] → 1.45% (-1.82%) [Q1 2025]
35% less funds holding
Funds holding: 17 [Q4 2024] → 11 (-6) [Q1 2025]
69% less capital invested
Capital invested by funds: $181K [Q4 2024] → $56.7K (-$125K) [Q1 2025]
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Research analyst outlook
We haven’t received any recent analyst ratings for FOXO.
Financial journalist opinion









